
TikTok’s CEO faces bipartisan skepticism in first Congressional hearing on security concerns
Marty Swant, Digiday
In June 2013, a settlement between Boiron, Inc. and consumers who filed a class-action lawsuit against it for allegedly falsely advertising its Children’s Coldcalm’s ability to relieve cold symptoms was preliminarily approved by a federal judge. According to the settlement terms, class members will get a full refund if they have their receipts (even without receipts, though, consumers who purchased Children’s Coldcalm may be entitled to some small reimbursement). (Delarose et al. v. Boiron, Inc., Case No. 10-cv-1569, C.D. Cal.)
Marty Swant, Digiday
Will it enforce them this time?
Lawsuit alleges beverage doesn’t meet federal standards to be marketed as rum.
TINA.org digs into company’s broad composting claims.
Unapproved drug claims abound.